United States · Who invested in Springleaf Therapeutics?
Springleaf Therapeutics's investors include Flybridge, North Bridge Venture Partners & Growth Equity, Excel Venture Management and GSK Venture Fund.
20102011
$4.2MSeries A$19MSeries BUnited States · Series B startup
Who invested in Springleaf Therapeutics
Funding summaryUpdated 26 Oct 2026
$23Mraised across 2 rounds since 2009, from 2 sources
$4.2MSeries A$19MSeries B
- Latest round
- Series B, $19MJul 2011
- Step-upi
- 4.5×
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $4.2M Nov 2009
- Biggest round
- $19M Series B · Jul 2011
- Between rounds
- 19 months from the last two
The rounds
- Jul 2011Series B$19M2 new
Reported by sec.govSEC filing: $19M sold, first sale Apr 2011
- Nov 2009
Founders and team
From the SEC filings it signed: 2 on the team.
- Frank BobeExecutive Officer, Directori
- Glenn LarsenExecutive Officeri
On the board, as filediBrian GallagherGaren BohlinJeffrey McCarthyKurt GravesMichael CimaMichael GreeleyYet-Ming Chiang
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series A2009Series B2011
Flybridge
North Bridge Venture Partners & Growth Equity
Excel Venture ManagementGSK Venture Fund
FlybridgeNorth Bridge Venture Partners & Growth EquityExcel Venture ManagementGSK Venture FundEveryone who backed them
GSK Venture FundGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Springleaf Therapeutics
How much has Springleaf Therapeutics raised?
Springleaf Therapeutics has raised $23M across 2 rounds since 2009.
When did Springleaf Therapeutics last raise?
Springleaf Therapeutics's most recent round was a Series B of $19M in Jul 2011.
What was Springleaf Therapeutics's biggest round?
Its most recent round, $19M in Jul 2011, is also its largest on record.
Who backed Springleaf Therapeutics first?
Springleaf Therapeutics's first round on record, in Nov 2009, was backed by Flybridge and North Bridge Venture Partners & Growth Equity.
What stage is Springleaf Therapeutics at?
Springleaf Therapeutics's latest named round is a Series B, in Jul 2011.
Where is Springleaf Therapeutics based?
Springleaf Therapeutics is based in the United States.
Companies like Springleaf Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.